ATON NASDAQ
AlphaTON Capital Corp.
1W: +15.5%
1M: +65.7%
3M: -8.3%
YTD: -50.2%
1Y: -95.4%
3Y: -99.4%
5Y: -99.9%
$0.36
-0.02 (-5.82%)
Weekly Expected Move ±25.2%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$0.8M
52W Range0.176-13.8
Volume15,825,210
Avg Volume5,236,825
Beta0.49
Dividend—
Analyst Ratings
Company Info
CEOBrittany Kaiser
Employees4
SectorFinancial Services
IndustryAsset Management
IPO Date2002-01-02
Websiteportagebiotech.com
Clarence Thomas Building
Road Town VG1110
US
Road Town VG1110
US
302 219 5556
About AlphaTON Capital Corp.
AlphaTON Capital Corp. is the rebranded entity formerly known as Portage Biotech Inc., a clinical-stage immuno-oncology company transitioning into a digital asset treasury model focused on accumulating and staking Toncoin (TON). AlphaTON intends to invest significantly in TON tokens, targeting a Long-Term TON treasury of approximately USâ¯$100 million.
Latest News
Anthony Scaramucci-Linked AlphaTON (ATON) Rebrands As Alpha Compute In 'Hard To Do' AI Pivot, CEO Terms Nvidia GPUs As 'Core' Balance Sheet Assets
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
AlphaTON Capital Executes Binding Call Option to Sell Legacy Biotech Asset iOx Therapeutics to Immunova
The Wall Street Minute and The Rhonda Swan Show: Wake Up New York Edition Announce Upcoming Filming with Ashley Holt, Enzo Villani - AlphaTON, and Benjamin Lee
Recent Insider Trades
No insider trades found